CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Hyundai Pharmaceutical Company Limited Company Snapshot
Hyundai Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hyundai Pharmaceutical Company Limited with three other companies in this sector in KOREA (SOUTH) : Theragen Etex Co Limited (2019 sales of 138.08 billion Korean Won [US$121.10 million] of which 86% was Pharmaceutical Business Segment), Dae Han New Pharm Co., Ltd. (134.10 billion Korean Won [US$117.60 million] of which 81% was Finished Goods), and Reyon Pharmaceutical Co Ltd (131.56 billion Korean Won [US$115.38 million] of which 33% was other finished goods).

Sales Analysis. During the year ended November of 2019, sales at Hyundai Pharmaceutical Company Limited were 134.92 billion Korean Won (US$118.33 million). This is a very small increase of 0.7% versus 2018, when the company's sales were 133.94 billion Korean Won . This was the fifth consecutive year of sales increases at Hyundai Pharmaceutical Company Limited (and since 2014, sales have increased a total of 25%). Sales of Food saw an increase that was more than double the company's growth rate: sales were up 12.2% in 2019, from 15.39 billion Korean Won to 17.26 billion Korean Won . Not all segments of Hyundai Pharmaceutical Company Limited experienced an increase in sales in 2019: sales of Pharmaceutical fell 7.6% to 109.53 billion Korean Won .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Hyundai Pharmaceutical Company Limited
  Stock Performance Chart for Hyundai Pharmaceutical Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (10/16/2020): 6,560.00
(Figures in Korean Won )
1 Week -0.9%   13 Weeks 6.0%  
4 Weeks 9.3%   52 Weeks 37.1%  
 
Hyundai Pharmaceutical Company Limited Key Data:
  Ticker: 004310 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 134,924,065,070
(Year Ending Jan 2020).
Employees: 398
  Currency: Korean Won Market Cap: 182,882,054,720
  Fiscal Yr Ends: November Shares Outstanding: 27,878,362
  Share Type: Common Closely Held Shares: 7,642,498
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.